Table of contents

Key facts

Invented name
  • Zeftera (previously Zevtera)
  • Zevtera and associated names
Active substance
Ceftobiprole medocaril (sodium)
Therapeutic area
Infectious diseases
Decision number
PIP number
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of pneumonia
Route(s) of administration
Intravenous use
Contact for public enquiries
Basilea Pharmaceutica International Ltd

E-mail: medical.information@basilea.com
Tel. +41 6160 61400

Decision type
PM: decision on the application for modification of an agreed PIP


Related content

How useful was this page?

Add your rating